相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Switching to Bictegravir, Emtricitabine, and Tenofovir Alafenamide in Virologically Suppressed Adults With Human Immunodeficiency Virus
Paul E. Sax et al.
CLINICAL INFECTIOUS DISEASES (2021)
Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in Adults With HIV and M184V/I Mutation
Ignacio Perez-Valero et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2021)
Long-term efficacy of dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: Week 96 results of ART-PRO pilot study
David Rial-Crestelo et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2021)
Deep sequencing analysis of M184V/I mutation at the switch and at the time of virological failure of boosted protease inhibitor plus lamivudine or boosted protease inhibitor maintenance strategy (substudy of the ANRS-MOBIDIP trial)
Constance Delaugerre et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2021)
Virological Outcome After Choice of Antiretroviral Regimen Guided by Proviral HIV-1 DNA Genotyping in a Real-Life Cohort of HIV-Infected Patients
Agnes Meybeck et al.
AIDS PATIENT CARE AND STDS (2020)
Routine drug resistance testing in HIV-1 proviral DNA, using an automated next-generation sequencing assay
Enagnon Kazali Alidjinou et al.
JOURNAL OF CLINICAL VIROLOGY (2019)
No impact of HIV-1 protease minority resistant variants on the virological response to a first-line PI-based regimen containing darunavir or atazanavir
Marine Perrier et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
Ultra-deep sequencing improves the detection of drug resistance in cellular DNA from HIV-infected patients on ART with suppressed viraemia
Christophe Rodriguez et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
Dynamics of drug resistance-associated mutations in HIV-1 DNA reverse transcriptase sequence during effective ART
A. Nouchi et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
Interest of proviral HIV-1 DNA genotypic resistance testing in virologically suppressed patients candidate for maintenance therapy
C. Allavena et al.
JOURNAL OF VIROLOGICAL METHODS (2018)
geno2pheno[ngs-freq]: a genotypic interpretation system for identifying viral drug resistance using next-generation sequencing data
Matthias Doering et al.
NUCLEIC ACIDS RESEARCH (2018)
Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults 2018 Recommendations of the International Antiviral Society-USA Panel
Michael S. Saag et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Clinically relevant thresholds for ultrasensitive HIV drug resistance testing: a multi-country nested case-control study
Seth C. Inzaule et al.
LANCET HIV (2018)
RNA and DNA Sanger sequencing versus next-generation sequencing for HIV-1 drug resistance testing in treatment-naive patients
E. K. Alidjinou et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
HIV-1 DNA ultra-deep sequencing analysis at initiation of the dual therapy dolutegravir plus lamivudine in the maintenance DOLULAM pilot study
Charlotte Charpentier et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
Deep sequencing for HIV-1 clinical management
Maria Casadella et al.
VIRUS RESEARCH (2017)
Deep Sequencing of HIV-1 RNA and DNA in Newly Diagnosed Patients with Baseline Drug Resistance Showed No Indications for Hidden Resistance and Is Biased by Strong Interference of Hypermutation
Kenny Dauwe et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2016)
Replication-Competent Noninduced Proviruses in the Latent Reservoir Increase Barrier to HIV-1 Cure
Ya-Chi Ho et al.
CELL (2013)
Quality control and preprocessing of metagenomic datasets
Robert Schmieder et al.
BIOINFORMATICS (2011)
FLASH: fast length adjustment of short reads to improve genome assemblies
Tanja Magoc et al.
BIOINFORMATICS (2011)
Historical HIV-RNA resistance test results are more informative than proviral DNA genotyping in cases of suppressed or residual viraemia
Marc Wirden et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Clinical management of HIV-1 resistance
Roger Paredes et al.
ANTIVIRAL RESEARCH (2010)